Skip Navigation


International Immunology Advance Access originally published online on May 17, 2005
International Immunology 2005 17(6):797-805; doi:10.1093/intimm/dxh260
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/6/797    most recent
dxh260v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tanaka, G.
Right arrow Articles by Izuhara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, G.
Right arrow Articles by Izuhara, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org

Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells

Go Tanaka1, Sachiko Kanaji1, Ayumi Hirano2, Kazuhiko Arima1, Akira Shinagawa2, Chiho Goda1, Shin'ichiro Yasunaga1, Koichi Ikizawa3, Yukiyoshi Yanagihara4, Masato Kubo5, Yoshiaki Kuriyama-Fujii6, Yuji Sugita2, Akira Inokuchi7 and Kenji Izuhara1,8

1 Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, 5-1-1 Nabeshima, Saga, 849-8501, Japan
2 Genox Research Inc., 5-12-8, Koishikawa, Tokyo, 112-8088, Japan
3 Hanno Research Center, Taiho Pharmaceutical Co., Ltd., 1-27, Misugidai, Hanno, 357-8527, Japan
4 Clinical Research Center, National Sagamihara Hospital, 18-1, Sakuradai, Sagamihara, 228-8522, Japan
5 RIKEN Research Center for Allergy and Immunology, (RCAI), RIKEN Yokohama Institute, Yokohama, 1-7-22, Suehiro-cho, Yokohama, 230-0045, Japan
6 Center for Tsukuba Advanced Research Alliance, University of Tsukuba, 1-1-1, Tenoudai, Tsukuba, 305-8577, Japan
7 Department of Otolaryngology-Head and Neck Surgery and 8 Division of Medical Research, Center for Comprehensive Community Medicine, Saga Medical School, 5-1-1 Nabeshima, Saga, 849-8501, Japan

Correspondence to: K. Izuhara; E-mail: kizuhara{at}med.saga-u.ac.jp

It is widely known that IL-4 and IL-13 act on various kinds of cells, including B cells, resulting in enhancement of proliferation, class switching to IgE and expression of several surface proteins. These functions are important for the recognition of the various antigens in B cells and are known to be involved in the pathogenesis of allergic diseases. However, it has not been known whether IL-4/IL-13 is involved in the metabolism of various kinds of xenobiotics including 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD), and it remains undetermined whether TCDD, an environmental pollutant, influences IgE production in B cells, exaggerating allergic reactions. We identified IL-4- or IL-13-inducible genes in a human Burkitt lymphoma cell line, DND-39, using microarray technology, in which the AHR gene was included. The AHR gene product, the aryl hydrocarbon receptor (AhR), was induced by IL-4 in both mouse and human B cells in a STAT6-dependent manner. IL-4 alone had the ability to translocate the induced AhR to the nuclei. TCDD, a ligand for AhR, rapidly degraded the induced AhR by the proteasomal pathway, although IL-4-activated AhR sustained its expression. AhR activated by IL-4 caused expression of a xenobiotic-metabolizing gene, CYP1A1, and TCDD synergistically acted on the induction of this gene by IL-4. However, the induction of AhR had no effect on IgE synthesis or CD23 expression. These results indicate that the metabolism of xenobiotics would be a novel biological function of IL-4 and IL-13 in B cells, whereas TCDD is not involved in IgE synthesis in B cells.

Keywords: CYP1A1, dioxin, gene regulation, microarray, xenobiotics

Transmitting editor: A. Falus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. Kobayashi, H. Okamoto, T. Iwamoto, Y. Toyama, T. Tomatsu, H. Yamanaka, and S. Momohara
A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis
Rheumatology, September 1, 2008; 47(9): 1317 - 1322.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. P. Lawrence, M. S. Denison, H. Novak, B. A. Vorderstrasse, N. Harrer, W. Neruda, C. Reichel, and M. Woisetschlager
Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound
Blood, August 15, 2008; 112(4): 1158 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. H. Thatcher, S. B. Maggirwar, C. J. Baglole, H. F. Lakatos, T. A. Gasiewicz, R. P. Phipps, and P. J. Sime
Aryl Hydrocarbon Receptor-Deficient Mice Develop Heightened Inflammatory Responses to Cigarette Smoke and Endotoxin Associated with Rapid Loss of the Nuclear Factor-{kappa}B Component RelB
Am. J. Pathol., March 1, 2007; 170(3): 855 - 864.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Goda, T. Kanaji, S. Kanaji, G. Tanaka, K. Arima, S. Ohno, and K. Izuhara
Involvement of IL-32 in activation-induced cell death in T cells
Int. Immunol., February 1, 2006; 18(2): 233 - 240.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.